BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 736430)

  • 1. [Oral photochemotherapy in vitiligo (author's transl)].
    Ortonne JP; Sannwald C; Thivolet J
    Ann Dermatol Venereol; 1978; 105(6-7):617-24. PubMed ID: 736430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative analytical study of the effects of psoralens in vitiligo (findings in 70 patients) (author's transl)].
    Bouattour H; Chaabouni M
    Ann Dermatol Venereol; 1978 May; 105(5):507-10. PubMed ID: 707943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and therapeutic effectiveness of 8-methoxypsoralen, 4,5',8-trimethylpsoralen, and psoralen in vitiligo.
    Pathak MA; Mosher DB; Fitzpatrick TB
    Natl Cancer Inst Monogr; 1984 Dec; 66():165-73. PubMed ID: 6531024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Repigmentation of vitiligo induced by oral photochemotherapy. Histoenzymological and ultrastructural study (author's transl)].
    Ortonne JP; MacDonald DM; Micoud A; Thivolet J
    Ann Dermatol Venereol; 1978 Nov; 105(11):939-40. PubMed ID: 754609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results in the treatment of vitiligo with oral khellin plus UVA.
    Hofer A; Kerl H; Wolf P
    Eur J Dermatol; 2001; 11(3):225-9. PubMed ID: 11358729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of vitiligo with oral methoxsalen and UVA.
    Lassus A; Halme K; Eskelinen A; Ranki A; Puska P; Salo O
    Photodermatol; 1984 Aug; 1(4):170-3. PubMed ID: 6531291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
    Parsad D; Kanwar AJ; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral phenylalanine loading and sunlight as source of UVA irradiation in vitiligo on the Caribbean island of Curacao NA.
    Kuiters GR; Hup JM; Siddiqui AH; Cormane RH
    J Trop Med Hyg; 1986 Jun; 89(3):149-55. PubMed ID: 3773027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy.
    Brazzelli V; Antoninetti M; Palazzini S; Barbagallo T; De Silvestri A; Borroni G
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1369-74. PubMed ID: 17958843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo.
    Lu-yan T; Wen-wen F; Lei-hong X; Yi J; Zhi-zhong Z
    Photodermatol Photoimmunol Photomed; 2006 Dec; 22(6):310-4. PubMed ID: 17100739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on the follicular melanocytes in the repigmented area of vitiligo after PUVA treatment (author's transl)].
    Fukuda S
    Nihon Hifuka Gakkai Zasshi; 1979 Apr; 89(5):355-67. PubMed ID: 313465
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
    Westerhof W; Nieuweboer-Krobotova L
    Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients.
    Hofer A; Hassan AS; Legat FJ; Kerl H; Wolf P
    Br J Dermatol; 2005 May; 152(5):981-5. PubMed ID: 15888156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral treatment of vitiligo with 8-methoxypsoralen and triamcinolone].
    Petzoldt D; Reich AL
    Hautarzt; 1974 Apr; 25(4):191-4. PubMed ID: 4849308
    [No Abstract]   [Full Text] [Related]  

  • 15. Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone.
    Bansal S; Sahoo B; Garg V
    Photodermatol Photoimmunol Photomed; 2013 Dec; 29(6):311-7. PubMed ID: 24118425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photochemotherapy of vitiligo. Use of orally administered psoralens and a high-intensity long-wave ultraviolet light system.
    Parrish JA; Fitzpatrick TB; Shea C; Pathak MA
    Arch Dermatol; 1976 Nov; 112(11):1531-4. PubMed ID: 984858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of optimal topical photochemotherapy for vitiligo.
    Grimes PE; Minus HR; Chakrabarti SG; Enterline J; Halder R; Gough JE; Kenney JA
    J Am Acad Dermatol; 1982 Dec; 7(6):771-8. PubMed ID: 7174915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy.
    Kanwar AJ; Dogra S; Parsad D; Kumar B
    Int J Dermatol; 2005 Jan; 44(1):57-60. PubMed ID: 15663664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outdoor and office photochemotherapy of vitiligo: a comparison.
    Wennersten G; Hägermark O
    Photodermatol; 1984 Apr; 1(2):91-3. PubMed ID: 6531288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of vitiligo with broadband ultraviolet B and vitamins.
    Don P; Iuga A; Dacko A; Hardick K
    Int J Dermatol; 2006 Jan; 45(1):63-5. PubMed ID: 16426381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.